< Back

November/December 2002, Vol. 4 No. 6
Approval times for new drugs fell by more than a year during PDUFA
View summary    Purchase single issue

September/October 2002, Vol. 4 No. 5
Tufts CSDD quantifies savings from boosting new drug R&D efficiency
View summary    Purchase single issue

July/Aug 2002, Vol. 4 No. 4
Approval Times for priority-reviewed new drugs declined under PDUFA
View summary    Purchase single issue

May/June 2002, Vol. 4 No. 3
Biotechnology has become vital to orphan product development
View summary    Purchase single issue

March/April 2002, Vol. 4 No. 2
Disease management cuts inpatient costs via greater drug spending
View summary    Purchase single issue

January/February 2002, Vol. 4 No. 1
Portfolio analysis links strategy to operations, improves performance
View summary    Purchase single issue